Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
about
Focus on adoptive T cell transfer trials in melanomaCD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expressionT cell avidity and tumor recognition: implications and therapeutic strategies.Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro.A simple and sensitive method for measuring tumor-specific T cell cytotoxicity.Strategies to genetically engineer T cells for cancer immunotherapy.4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignanciesImmunotherapy of human cancers using gene modified T lymphocytes.Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in miceTargeted immunotherapy of cancer with CAR T cells: achievements and challenges.Engineering T cell function using chimeric antigen receptors identified using a DNA library approachThe promise and potential pitfalls of chimeric antigen receptors.Targeting tumours with genetically enhanced T lymphocytes.Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells.Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaTargeting cytotoxic T lymphocytes for cancer immunotherapy.Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells.A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.Supernatural T cells: genetic modification of T cells for cancer therapy.Designed ankyrin repeat proteins are effective targeting elements for chimeric antigen receptors.Improving T cell therapy for cancer.Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cellsAn Influenza Virus M2 Protein Specific Chimeric Antigen Receptor Modulates Influenza A/WSN/33 H1N1 Infection In VivoT Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice.Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.The development of novel immunotherapeutic approaches in multiple myeloma.Second-generation anti-carcinoembryonic antigen designer T cells resist activation-induced cell death, proliferate on tumor contact, secrete cytokines, and exhibit superior antitumor activity in vivo: a preclinical evaluation.Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemiaConstruction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.Treatment of lymphoma with adoptively transferred T cells.Genetic redirection of T cells for cancer therapy.Chimeric antigen receptor-engineered T cells for immunotherapy of cancer.Advances in the development of cancer immunotherapies.Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.CD19 chimeric antigen receptor T cell therapy for haematological malignancies.Beginning of a novel frontier: T-cell-directed immune manipulation in lymphomas.Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone.How Chimeric Antigen Receptor Design Affects Adoptive T Cell Therapy.Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade.A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor.
P2860
Q21328679-4F55D47F-DD86-4756-9EDC-4464DCE9EE72Q24808883-4998008D-DA46-46EE-B349-80224D005FEDQ24815775-41F49B70-B11E-44BF-9C01-161A2FDD487EQ25257888-19409B89-FC54-451B-9E4E-787A409C5414Q33649655-5332ADBE-501A-480F-A98D-B58F1CACF6F5Q33655849-80F08C27-785F-4E53-BD37-A6F47AC88DFFQ33819935-05D27DAA-6749-4EED-B750-A5BCBA6404A2Q34188383-56C008D1-B45C-4099-B11C-00622F68A640Q34244875-FD08D0D4-7976-4C1D-AB2C-08007066FE24Q34270375-C0CFF4FC-AB01-43DF-A374-049EEC8AB5D3Q34717977-31E3B751-5401-4305-98ED-49819077937EQ34970378-42B07E5E-FD9C-46E9-A89B-32AD5CF76D72Q35037678-E5D787A0-2B5A-43CD-B898-16A3798B1D8EQ35111932-B21682E8-50F3-49B4-A4D4-75D8C540B7D1Q35604043-80D52DAA-64C7-44A6-B9F0-149BABB89751Q35842135-3DC012F4-779B-4A6B-960D-23D858118DD7Q35847820-A50A7315-4176-4ED0-9D77-67905BFB0842Q36299662-2257D1C3-8858-4271-9523-5160DF6ACB19Q36328805-8132264C-C34F-4C52-A133-AD2249927B6FQ36370414-D337BDDA-11A3-436E-B5F8-E23EC5F27AEDQ36407236-2937CA2D-1078-4FDB-9EB6-75632DD7C433Q36470354-0B63AFAB-B803-49E8-818D-6F1D6CE7D56DQ36675921-F25F6A45-C86D-42E2-B1CA-64C22082B347Q36757142-877E761D-DE88-4DD7-9730-E932862825AEQ37117781-48F0C57F-62A5-481B-B3DA-1DD573642291Q37132883-2630E337-7149-4924-B491-082326BEB8BFQ37137406-8EE04B8F-516B-42D5-9833-C1A7F88C6DE2Q37316845-4ED38B07-DE3F-43A3-B12A-A1627FA2CE09Q37354362-CF16A9A9-D6FA-4F5A-B35B-4E733A78996DQ37419728-3B675334-8C81-4520-A9D6-2B6773105F00Q37697337-172DA12D-29DE-4EB2-9649-087FB26A2367Q37751873-12CA81F4-E216-40B8-B7E3-497D395722B8Q38049010-2B06669C-74A8-4FC9-AFF9-6C5888F27DEDQ38324896-53C16C2B-630F-4102-8D23-591FEB02D897Q38370975-100273D6-4E57-477B-99CA-187BF837D691Q38637599-C37E77BF-CCE5-4805-B943-3206734EA86CQ38823747-9EAE5433-E408-4002-9588-9EE45D87EF2AQ38830813-D6A4A97D-2EE1-4348-863C-7D78FA1186EEQ38874911-605F54FE-6141-4636-A4A5-AF3FAB385632Q38983814-05C968A1-EEA5-4B5C-9965-00FE8B893A43
P2860
Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Single-chain antigen recogniti ...... tablished experimental tumors.
@en
Single-chain antigen recogniti ...... tablished experimental tumors.
@nl
type
label
Single-chain antigen recogniti ...... tablished experimental tumors.
@en
Single-chain antigen recogniti ...... tablished experimental tumors.
@nl
prefLabel
Single-chain antigen recogniti ...... tablished experimental tumors.
@en
Single-chain antigen recogniti ...... tablished experimental tumors.
@nl
P2093
P50
P1433
P1476
Single-chain antigen recogniti ...... tablished experimental tumors.
@en
P2093
Jacob T Jackson
Loretta Cerruti
Michèle W L Teng
Nicole M Haynes
P304
P356
10.1182/BLOOD-2002-04-1041
P407
P577
2002-11-01T00:00:00Z